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Edited by Lukas HuberAbstract Glycosylation of proteins can modulate their function
in a striking variety of systems, including immune responses,
neuronal activities and development. The Drosophila protein,
Chaoptin (Chp), is essential for the development and mainte-
nance of photoreceptor cells. This protein is heavily glycosylated,
but the possible role of this glycosylation is not well-understood.
Here we show that mutations introduced into about 1/3 of 16 po-
tential N-linked glycosylation sites within Chp impaired its cell
adhesive activities when expressed in Drosophila S2 cells. Muta-
tion of 2/3 of the glycosylation sites resulted in a marked de-
crease in Chp protein abundance. These results suggest that N-
linked glycosylation of Chp is essential for its stability and activ-
ity.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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rich repeat1. Introduction
The cell surface is covered with various glycans attached to
proteins and lipids. These glycans are involved in diverse func-
tions including intercellular signaling, extracellular matrix for-
mation and cell attachment/adhesion [1,2]. Glycoproteins
having adhesive properties are used for intercellular adhesion
or intracellular architectural formation. For example, Cadher-
ins mediate cell-to-cell adhesion [3] while Drosophila Chaoptin
(Chp) is required for formation of a tightly packed microvilli
structure, the rhabdomere, within a photoreceptor cell [4].
The rhabdomere is the cell domain within which Rhodopsins
accumulate and photo-transduction occurs. The Drosophila
mutant chaoptic is defective in chp and these ﬂies show no
rhabdomere accumulation and no light sensing activity [5].
Chp is a glycosylphosphatidylinosotol (GPI)-anchored pro-
tein containing 41 leucine-rich repeats (LRR) [5], each of
which is generally 20–29 residues long and contains a con-
served 11-residue segment having the consensus sequenceAbbreviations: Chp, Chaoptin; GPI, Glycosylphosphatidylinosotol;
LRR, leucine-rich repeat; TLR, Toll-like receptor; ER, endoplasmic
reticulum; ERAD, ER-associated degradation
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doi:10.1016/j.febslet.2008.06.028LxxLxLxxN/CxL [6]. LRRs are protein–protein interaction
domains found in hormone receptors, tyrosine kinase recep-
tors, bacterial virulence factors, enzymes, extracellular ma-
trix-binding glycoproteins, and cell-adhesion molecules.
Consistently, when Chp is expressed in non-adherent S2 cells,
the cells form aggregates, suggesting that Chp has homotypic
cell-adhesive activity [7].
Chp is known to be heavily modiﬁed with N-glycans and
these modiﬁcations could potentially occur at 16 sites contain-
ing the sequences Asn-Xaa-Ser/Thr. However, the structures
and roles of these glycans remain to be elucidated. The role
of glycans attached to the LRRs of another family of proteins,
the Toll-like receptors (TLR), has been better studied. TLRs
play key roles in activating innate immune responses during
infection and recognize a variety of pathogen-associated mol-
ecules [8]. Site-directed mutagenesis of the N-glycosylation
sites of the TLRs has shown that these modiﬁcations aﬀect
secretion, ligand binding and formation of the receptor com-
plex [9–12].
In this report, we studied the role of N-glycans on Chp by
introducing amino acid substitutions at the acceptor sites for
N-linked glycosylation. Since the glycosylation sites are clus-
tered in three domains within Chp (Fig. 1), we mutated all
of the glycosylation sites in individual or multiple domains.
When we introduced mutations into the glycosylation sites in
one of the three domains, the mutated Chp expressed in S2
cells was transported to the plasma membrane but failed to
form cell aggregates. In contrast, when sites in more than
one domain were mutated, expression of Chp was markedly re-
duced and, in some cases, Chp was degraded. These results
indicate that the N-glycosylation of Chp is required for its cell
adhesive activity and stability.2. Materials and methods
2.1. DNA constructions
The Chp coding sequence was ampliﬁed from the Drosophila
Genomics Resource Center clone GH19649 using the oligonucleotides
chpN, 5 0-CCGCTCGAGATTTAATTTACAGCAAAATGGGCC-3 0
and chpC, 5 0-GACTAGTTCACATCCAGAAGACCATGGCCAC-
3 0. The ampliﬁed fragment was inserted into the XhoI and SpeI sites
of the pMK33/pMtHy plasmid to generate pMK33/pMtHy/chp. The
plasmid pMK33/pMtHy/chp was used for the expression of Chp, un-
der the control of the metallothionein-inducible promoter. Targeted
point mutations were introduced into Chp using Quickchange site-di-
rected mutagenesis [13]. Sequences of the reverse primers used to
generate mutant Chp shown in Fig. 1 are described in Supplementary
data 1.blished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic illustration of potential N-glycosylation sites on
Chp. The sites corresponding to putative N-glycosylation sites are
shown by Y. The squares in wild-type Chp indicate the LRRs. The
crosses represent the mutation of each N-glycan site by site-directed
mutagenesis.
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S2 cells were grown as a monolayer at 25 C with 5% CO2 in Schnei-
ders medium supplemented with 10% heat-inactivated FCS, 100 U/ml
penicillin and 100 lg/ml streptomycin. Cells were transfected by cal-
cium phosphate method (Invitrogen). Transfected cells were selected
with 300 lg/ml hygromycin B (Invitrogen). Induction of Chp expres-
sion was performed by incubating cells in the presence of 10 mM
CuSO4 overnight.
2.3. Western blot analysis
For Western blot analysis, a mouse anti-Chp monoclonal antibody
(chpN8A) was generated by immunization with the synthetic peptide
(SMFDREMEETHY) representing the N terminus of Chp. 2 lg of
S2 cell lysates were subjected to SDS–PAGE and immunoblotting.
Anti-Chp (chpN8A) and polyclonal anti c-tubulin (GTU88) (Sigma)
antibodies were used as the primary antibodies, while HRP-conjugated
anti-mouse and anti-rabbit IgG antibody (Jackson Immunoresearch)
was used as the secondary antibodies. Super Signal (Pierce) was used
for detection. Treatment with PNGase F or endoglycosidase H (Endo
H) (New England Biolabs) was performed according to the manufac-
turers instruction. The digested proteins were analyzed by immuno-
blotting.
2.4. RT-PCR analysis
2 · 106 cells expressing wild-type or each mutant were washed in
PBS and total RNA was extracted with the RNeasy mini prep kit (Qia-
gen). cDNA synthesis was performed by First Strand Synthesis Kit
(Invitrogen) according the manufactures instructions. Expression of
Chp was analyzed by performing an 18-cycle PCR using ﬁrst-strand
cDNAs and the following primers: forward 5 0-AGA-
ACTCGCTGATCAAACTGG-3 0 and reverse 5 0-
CTTCTTCAGGTTCCTGTTGTG-30. The cDNAs were normalized
against the c-tubulin transcript. The primers were as follows: forward
5 0-ATGCCAAGTGAAATAATTACTTTGCAGCTTGGG-3 0; and
reverse, 5 0-CTAGGAACCGGCGCTGGTCACAGATCGACTATC-
3 0.
2.5. Immunostaining
For staining of whole Chp, cells expressing wild-type or mutant of
Chp were ﬁxed with 4% paraformaldehyde in PBS. Chp was visualized
by incubating cells with mouse anti-Chp antibody clone 24B10 (dilu-
tion 1:20, University of Iowa DSHB) [14] or mouse anti-Chp antibody
clone chpN8A (dilution 1:20), followed by incubation with Alexa 488-
conjugated anti-mouse IgG (dilution 1:500, Molecular Probes). Nuclei
were stained with TO-PRO-3 (dilution 1:1000, Molecular Probes). Sur-
face Chp was detected by incubation with ﬁrst antibody without prior
ﬁxation of cells.2.6. Cell aggregation assay
Cell aggregation assay was carried out as described previously [7].
Stable cell lines were incubated overnight at 25 C in the presence of
10 mM CuSO4. 2 · 105 cells were incubated at 25 C for 0.5–3 h in a
24-well culture dish on a rotating platform.3. Results
3.1. Mutation of potential Chp N-glycosylation sites
Chp contains 16 potential N-glycosylation sites (Asn-Xaa-
Ser/Thr), Asn-77, Asn-267, Asn-305, Asn-339, Asn-361, Asn-
422, Asn-680, Asn-692, Asn-718, Asn-746, Asn-936, Asn-970,
Asn-1012, Asn-1122, Asn-1152, and Asn-1171, and these gly-
cosylation sites are clustered in three domains within Chp as
shown in Fig. 1. To investigate which N-glycan sites are
responsible for Chp function, we prepared mutant forms of
Chp in which the glycosylation sites in one or more domains
are mutated from Asn to Glu (Fig. 1). The mutant forms of
Chp were expressed in S2 cells that were previously used to as-
say Chp-mediated aggregation. Chp-expressing cells were se-
lected by hygromycin.3.2. Expression of chp mutants in S2 cells
To study the glycosylation status of Chp expressed in S2
cells, we treated cell lysates with PNGase F, an enzyme that re-
moves all types of N-linked glycosylation, or with Endo H, an
enzyme that hydrolyzes the N,N 0-diacetylchitobiosyl unit in
high-mannose glycopeptides and glycoproteins containing the
-[Man(GlcNAc)2]Asn structure. As shown in Fig. 2A, the
molecular weight of the wild-type Chp expressed in S2 cells
is about 160 kDa as estimated by SDS–PAGE. This molecular
weight is the same with that of Chp puriﬁed from Drosophila
eyes. When the Chp expressed in S2 cells was treated with
PNGase F, the apparent molecular weight decreased to about
140 kDa (Fig. 2A), which is consistent with that calculated by
the unconjugated amino acid composition of Chp. The appar-
ent molecular weight of Chp treated with EndoH was slightly
larger than that observed following PNGase F treatment. This
is probably due to remaining GlcNAc moieties attached to
Chp, as EndoH digests the glycosidic bond between two Glc-
NAcs in the trimannosyl core of N-glycans and does not com-
pletely remove the entire modiﬁcation. In addition, removal of
the putative N-glycosylation sites on each domain of Chp (m1,
m2 and m3) resulted in a decrease in molecular weight com-
pared with the wild-type (Fig. 2B). This suggests that all of
these domains contain attached N-glycans. These results sug-
gest that Chp expressed in S2 cells is heavily glycosylated, as
is observed for Chp isolated from Drosophila eyes (M. Y-H.
and S. G., unpublished data).
We ﬁrst studied whether the glycosylation of Chp is required
for its stability. When we expressed mutated Chp derivatives
that lack N-glycosylation sites in individual domains (m1,
m2 and m3) we found that they expressed lower levels than
the wild-type protein (Fig. 2B). Moreover, when Chp was mu-
tated in two domains (m4–m6), its abundance in the S2 cells
was markedly reduced compared to both the wild-type and
individual m1–m3 mutants (Fig. 2B). We also found that the
m5 and m7 forms of Chp migrated faster on SDS–PAGE than
the wild-type Chp treated with PNGase F (Fig. 2A and B).
This suggests that Chp might not only be deglycosylated, but
may also be cleaved within the protein.
Fig. 2. Expression of Chp mutants in S2 cells. (A) Glycosidase
sensitivity of wild-type Chp expressed in S2 cells. (B) Immunoblot
analysis of total protein extracted from S2 cells expressing wild-type or
N-glycosylation mutants of Chp using anti-Chp antibody (N8A). The
membrane was also probed for c-tubulin as a loading control. (C) RT-
PCR of mRNA from S2 cells expressing wild-type or N-glycosylation
mutants of Chp. Total RNA was prepared from harvested cells and
quantiﬁed by RT-PCR of Chp transcripts, normalized to c-tubulin
mRNA.
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than one domain were not eﬃciently expressed in S2 cells, ex-
cept for the m7 form. This increase in the m7 form, which has
no N-glycans, is consistent with a previous report showing that
inhibition of N-linked glycosylation by tunicamycin increases
the steady-state levels of misfolded opsin, suggesting that N-
linked glycosylation is required for degradation of misfolded
proteins [15]. In contrast, we observed ectopic cleavage of
the m5 form, which has fewer N-glycans. This strongly sug-Fig. 3. Cell surface localization of Chp mutants. Confocal microscope image
S2 cells expressing wild-type or m1–m7 mutants of Chp. The cells were stained
m7 mutants were not detectable. Nuclei were stained with TO-PRO-3 (blue)gests that the poor expression of the mutant Chps could be
due to their rapid degradation. Another possibility is that
the mutant mRNAs are less stable. To test this possibility,
we performed an RT-PCR assay. Cells expressing the mutant
forms contained almost the same amounts of chp mRNA as
did cells expressing the wild-type (Fig. 2C), indicating that
the failure of the mutants to be eﬃciently expressed may result
from rapid degradation of the protein and not the mRNA.
These results, together with the observed prominent cleavage
of m5 and m7, suggest that the N-glycans, especially those in
domains 2 and 3, play essential roles in the stability of Chp.
3.3. Localization of chp mutants on the cell surface
We further investigated the subcellular localization of the
mutant forms of Chp expressed in S2 cells. As indicated in
Fig. 3, the m1, m2, and m3 mutants were transported to the
proximity of the cell surface with the same eﬃciency as the
wild-type. These mutant forms of Chp could also be detected
by anti-Chp antibody using non-permeabilized cells, indicating
that the proteins reaching the cell surface face the outside of
the cell. However, in the case of the m2 mutant, the intensity
of surface Chp staining was weaker than those of either the
other mutants or of wild-type, suggesting that not all of the
m2 mutant protein is transported to the cell surface. In addi-
tion, m5 mutant staining appeared as intracellular dots, which
were not detectable using non-permeabilized cells, suggesting
that the m5 mutant was sequestered within an intracellular
compartment and failed to be secreted. The same results were
obtained using another anti-Chp antibody (N8A) that recog-
nizes a diﬀerent epitope within Chp, indicating that these dif-
ferent staining were not caused by the biased accessibility of
the antibody to Chp (data not shown). In summary, Chp
was not eﬃciently transported to the cell surface or it accumu-
lated in an intracellular compartment when N-glycans in do-
main 2 or in both domains 1 and 2 were missing,
respectively. This suggests that N-glycosylation of Chp, espe-
cially in domain 2, is essential for its localization to the cell sur-
face.
3.4. Role of Chp N-glycosylation on cell adhesion
Since the m1, m2 and m3 mutant forms of Chp are expressed
on the cell surface, we next asked whether these mutants have
cell adhesive activity. To approach this question, we ﬁrst se-
lected stable cell lines expressing comparable levels of the
wild-type and mutant Chp, following quantitation of the pro-
tein using anti-Chp antibody (N8A) (Fig. 4C). The selected
cells were dissociated into single cells by trituration and incu-s of permeabilized (upper panels) and non-permeabilized (lower panels)
with the anti-Chp antibody (24B10, green). Staining of the m4, m6 and
. Scale bars, 10 lm.
Fig. 4. The role Chp N-glycosylation in cell adhesion. (A) Cell clusters were formed during adhesion assays. S2 cells expressing the wild-type or m1,
m2, or m3 mutant Chp were assayed for cell adhesion as described in Section 2. Scale bars, 200 lm. (B) Changes in particle number as a function of
time. A particle is deﬁned as a single cell, or a cluster of a few cells. Nt/N0 represents the ratio of the number of particles counted at a given time point
(Nt) relative to the number of particles observed at the beginning of the assay (N0). Mean and standard deviation (n = 3) is plotted for S2 cells
expressing wild-type or m1, m2, or m3 mutants that were assayed in parallel. (C) Immunoblot analysis of total proteins extracted from S2 cells
expressing wild-type or N-glycosylation-defective Chp mutants using anti-Chp antibody (N8A). Membrane was also probed for c-tubulin as loading
control.
Y. Hirai-Fujita et al. / FEBS Letters 582 (2008) 2572–2576 2575bated with agitation for 3 h. Following incubation for 30 min,
large aggregates of S2 cells were formed when wild-type Chp
was expressed but no aggregates were formed when with cells
expressing the m1, m2 or m3 mutants (Fig. 4A). We further
performed quantitative analysis by counting the number of
particles in the aggregation assay: ‘‘particles’’ in this assay
can consist of a single cells or clumps of a few cells. As cells
aggregate, the total number of particles decreases. Aliquots
from the suspensions were removed at various times and the
number of particles were counted using a hemocytometer.
The number of particles markedly decreased within 30 min
with cells expressing wild-type Chp, but remained approxi-
mately constant up to 3 h with cells expressing the m1, m2
or m3 mutants (Fig. 4B). Furthermore, we counted the number
of cell aggregates per 1 mm3 and found that about 100 aggre-
gates were formed in the assay for the wild-type but none for
the mutants (data not shown). These results strongly suggest
that the N-glycosylation of Chp is critical for its cell adhesive
activity.4. Discussion
In this study, we provide the ﬁrst evidence showing that N-
glycosylation of Chp plays critical roles in its protein stability
and cell adhesive activity. When N-glycosylation sites were
mutated in more than one domain, the amount of Chp pro-
tein in the cell was markedly reduced. In particular, mutantChp lacking glycans in domains 2 and 3, or in all domain,
were apparently cleaved. These results raise two possibilities:
(1) endoplasmic reticulum (ER)-stress may be induced by
deglycosylated Chp or (2) deglycosylated Chp may be mis-
sorted to compartments, such as the lysosome, where it is de-
graded. In general, glycosylation of secretory and membrane
proteins occurs during translational in the lumen of the ER.
N-glycans initially serve to increase the hydrophilicity of the
as-yet-unstructured nascent polypeptides. N-linked oligosac-
charides facilitate interactions with chaperones such as Caln-
exin and Calreticulin to promote protein maturation [16,17].
The immature, folding-defective polypeptides are retro-trans-
located into the cytosol and undergo proteasome-operated
disposal, a process known as ER-associated degradation
(ERAD) [18]. For example, Rh1, the major Rhodopsin spe-
cies in Drosophila, undergoes N-linked glycosylation during
biosynthesis in the photoreceptor cells [19]. Previous studies
indicate that Rh1 does not maturate and accumulates in
the ER in cells mutant for Calnexin 99A, one of three Caln-
exin homologs in Drosophila [20]. Mutated Rh1 lacking its N-
Glycosylation site also accumulates in the ER and evokes
ERAD [21]. In contrast, Chp is normally localized to the cell
surface in calnexin 99A mutants and the mutant Chp we gen-
erated did not accumulate in the ER [20]. Moreover, the m5
mutant was mis-sorted to an unknown intracellular compart-
ment. These results suggest that lack of N-glycosylation
causes Chp to be mis-sorted to the incorrect compartment
and degraded.
2576 Y. Hirai-Fujita et al. / FEBS Letters 582 (2008) 2572–2576Loss of N-glycosylation in one of the three domains of Chp
abrogates its adhesive properties. Each domain contains N-gly-
cosylation sites in its LRR motifs, suggesting that LRR glyco-
sylation is important for normal protein function. For
example, glycosylation of the LRR-containing TLRs, has been
shown to be essential for the activities of this family of recep-
tors. Mutants of TLR2 and 3 defective in glycosylation are un-
able to activate NF-kB, probably because ligand binding or
receptor complex formation is defective [10–12]. Mutants of
TLR4 lacking its N-glycosylation sites do not response to
LPS stimulation [9]. Recently, the three-dimensional structures
of some LRR proteins binding to their ligand or associated
protein have been reported. The structures of typical LRR
proteins show that the ligand or associated protein binds to
a concave surface within the solenoid structure of the LRR
b-sheet [22–24]. In contrast, TLR1 and 2 have a crevice in their
convex regions, and the binding of lipopeptides induces the
formation of an M-shaped heterodimer [25]. TLR3 also has
a ligand-binding domain within its convex region [26–28]. In
the case of Chp, although the domain required for oligomeri-
zation has not been identiﬁed, it will be interesting to study
which glycans on the concave or the other surfaces of Chp
are required for its binding activity.
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